ArticleJMIR research protocols2026
Mathematical Prediction Models for Sentinel Node Status in Early-Stage Breast Cancer: Protocol for a Systematic Review.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe status of the axilla remains a significant prognostic factor and influences adjuvant systemic and locoregional treatment choices in early-stage breast cancer (EBC). Sentinel node (SN) biopsy continues to be the preferred technique for establishing axillary nodal status in clinically node-negative EBC. A multivariable prediction model with adequate accuracy and generalizability has been explored as a potential alternative to SN.
objectiveThis systematic review aims to evaluate the predictive performance, methodological quality, and risk of bias associated with the available mathematical models (MMs), excluding artificial intelligence (AI)-based models, for predicting SN status in patients with EBC.
methodsA systematic search will be conducted across PubMed, Cochrane CENTRAL, and Embase to identify studies reporting the development of an SN status prediction model. Only studies that report SN status using mathematical modeling techniques will be included. Two independent reviewers will screen the search results and extract data from the included articles. The primary outcome of this systematic review is to evaluate the methodological adequacy and generalizability of individual MMs and compare the reported predictive performances of methodologically robust MMs. The secondary objective is to identify key predictive factors contributing to SN status prediction in MMs. A narrative synthesis of all the included studies will be undertaken. The details of this protocol are accessible on PROSPERO, where it was registered on January 23, 2025. Ethics approval is not required for this study because only published data will be analyzed.
resultsFunding for this review was obtained in 2022. The literature search was completed on December 15, 2023, and screening began in December 2023. Data extraction and assessment using the Prediction Model Risk of Bias Assessment Tool was completed by December 2025, with synthesis planned for March 2026. Of the 3458 screened records, 122 (3.5%) were selected for data extraction. Results will be prepared for submission for a peer review and publication in mid-2026.
conclusionsThis review will provide a consolidated evaluation of non-machine learning MMs for predicting SN status in EBC. By clarifying the predictive performance and methodological quality of traditional statistical approaches, the findings will serve as a benchmark against which emerging AI-based tools can be compared. This review is also expected to identify predictors that consistently contribute to accurate modeling, informing the development of future statistical and AI-enhanced prediction tools.
trial registrationPROSPERO CRD42025637632; https://www.crd.york.ac.uk/PROSPERO/view/CRD42025637632. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/82523.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.